Benzbromaron ( DrugBank: - )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
86	Pulmonary arterial hypertension	2

86. Pulmonary arterial hypertension

---

Clinical trials : 1,205 /  Drugs : 684 - (DrugBank : 124) / Drug target genes : 100 - Drug target pathways : 193

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2015-000709-38-AT (EUCTR)	20/10/2015	28/07/2015	Effects of the drug Benzbromaron on the pulmonary vessels	Acute Effects of Benzbromaron on the pulmonary circulation	Pulmonary arterial hypertension MedDRA version: 18.1;Level: PT;Classification code 10064911;Term: Pulmonary arterial hypertension;System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]	Trade Name: Benzbromaron AL Product Name: Benzbromaron INN or Proposed INN: BENZBROMARONE	Medical University of Graz	NULL	Not Recruiting			Female: yes Male: yes		Phase 2	Austria
2	NCT02790450 (ClinicalTrials.gov)	October 2015	30/5/2016	Acute Effects of Benzbromaron on the Pulmonary Circulation	Acute Effects of Benzbromaron on the Pulmonary Circulation	Idiopathic Pulmonary Arterial Hypertension	Drug: Benzbromarone	Medical University of Graz	Ludwig Boltzmann Institute for Lung Vascular Research	Completed	18 Years	90 Years	Both	10	Phase 2	Austria